Ascentage Pharma Group Stock Probability of Future Pink Sheet Price Finishing Over 0.0

ASPHF Stock  USD 2.50  0.00  0.00%   
Ascentage Pharma's future price is the expected price of Ascentage Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ascentage Pharma Group performance during a given time horizon utilizing its historical volatility. Check out Ascentage Pharma Backtesting, Ascentage Pharma Valuation, Ascentage Pharma Correlation, Ascentage Pharma Hype Analysis, Ascentage Pharma Volatility, Ascentage Pharma History as well as Ascentage Pharma Performance.
  
Please specify Ascentage Pharma's target price for which you would like Ascentage Pharma odds to be computed.

Ascentage Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascentage Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascentage Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M.
Ascentage Pharma generates negative cash flow from operations
About 27.0% of the company shares are held by company insiders

Ascentage Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascentage Pink Sheet often depends not only on the future outlook of the current and potential Ascentage Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascentage Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding262.8 M

Ascentage Pharma Technical Analysis

Ascentage Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ascentage Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascentage Pharma Group. In general, you should focus on analyzing Ascentage Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Ascentage Pharma Predictive Forecast Models

Ascentage Pharma's time-series forecasting models is one of many Ascentage Pharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ascentage Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Ascentage Pharma

Checking the ongoing alerts about Ascentage Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ascentage Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M.
Ascentage Pharma generates negative cash flow from operations
About 27.0% of the company shares are held by company insiders
Check out Ascentage Pharma Backtesting, Ascentage Pharma Valuation, Ascentage Pharma Correlation, Ascentage Pharma Hype Analysis, Ascentage Pharma Volatility, Ascentage Pharma History as well as Ascentage Pharma Performance.
Note that the Ascentage Pharma information on this page should be used as a complementary analysis to other Ascentage Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Ascentage Pink Sheet analysis

When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Please note, there is a significant difference between Ascentage Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascentage Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascentage Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.